NCI’s ComboMATCH initiative will test new drug combinations guided by tumor biology

2 years ago 56
ComboMATCH will consist of numerous phase 2 cancer treatment trials that aim to identify promising drug combinations that can advance to larger, more definitive clinical trials.
Read Entire Article